Lecture 19 - Breast Cancer Flashcards

(31 cards)

1
Q

What 4 3’s do I need to know for the exam?

A
  • Describe 3 risk factors for breast cancer
  • Name 3 sub-types of breast cancer
  • What is triple assessment?
  • Discuss 3 treatment options
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the incidence of breast cancer

A
  • most common cancer in UK
  • around 50,000 women and 400 men diagnosed each year
  • 1/8 women will be diagnosed in her lifetime
  • 12,000 women and 8- men will die from breast cancer each year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the trend in incidence and mortality of breast cancer?

A
incidence = rising 
mortality = decreasing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does survival rate vary by stage? Why is this important?

A

survival decreases dramatically with each increasing stage

- early diagnosis essential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the risk factors for breast cancer?

A
  • age
  • geographic location
  • oestrogen exposure
  • family history
  • previous breast cancer
  • exogenous hormones
  • BMI
  • ionising radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the NHS breast screening programme

A
  • introduced in 1988
  • 50-70
  • 3 yearly intervals
  • digital mammograms
  • estimated 1000 deaths prevented
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What socioeconomic factors affect breast cancer risk?

A
  • high SES
  • age at first pregnancy - younger = protection
  • number of children - more = protection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What reproductive factors affect breast cancer risk?

A
  • early onset menarche
  • late menopause
  • older age at first pregnancy
  • nulliparity, each birth reduces the risk by 7% (15% in women with a twin birth)
  • longer duration of breastfeeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What lifestyle factors affect breast cancer risk and the molecular basis for their risk?

A

Obesity
- activation of IGF-1 and insulin signalling pathways
- activation of PI3K/Akt/mTOR signalling pathways
- increased production of oestrogen
- increased production of adipokines (e.g. leptin)
Alcohol
- effect of actaldehyde
- epigenetic changes (DNA methylation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the prevalence of the BRCA genes?

A

0.2-0.3% in general population
3% in women with breast cancer
6% in women with breast cancer onset before age 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What subtype are most of the BRCA1 cancers?

A
  • basal-like
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What gene is the major high-penetrance predisposition gene for luminal (ER positive) breast cancers?

A

BRCA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the two major histological types of breast cancer

A

Ductal carcinoma in situ = DCIS
- incidence increasing
- 30-50% chance of processing to invasive cancer
Lobule carcinoma in situ = LCIS
- marker of increased risk (8-10 fold) for ILC rather than a true precursor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the main types of invasive breast cancer?

A
ductal/NST
lobular 
tubular
mucinous
papillary 
others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the transition from in situ to metastatic breast cancer

A

BM intact
in situ changes, including nuclear changes
invasion –> BM disruption
blood vessels and lymph invasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the major molecular subtypes of breast cancer?

A
  • Basal-like (BRCA1/triple-begative)
  • Luminal A (ER+, HER2-)
  • Luminal B (ER+, HER2+)
  • HER2
  • Claudin-low
  • Normal like
17
Q

Why is it important to find out the molecular characteristics of a breast cancer?

A
  • guide treatment

- estimate prognosis

18
Q

Which is the worst and best molecular profile of a breast cancer?

A

triple negative = worst

O, P +ve = best

19
Q

What are the 3 things involved in the management?

A

diagnosis
surgery
adjuvant therapy

20
Q

Who forms part of the diagnostic team?

A
  • breast clinician (consultant surgeon)
  • radiologist and radiographer
  • pathologist
  • breast care nurse
  • nurse practitioner
  • clinic staff
  • administrative staff
  • dedicated MDT coordinator
21
Q

Who forms part of the treatment team?

A
  • clinical oncologist
  • medical oncologist
  • breast surgeon
  • medical geneticist
  • data management personnel
  • research nurse
  • lymphedema specialist
  • medical prosthetist
  • clinical psychologist
  • palliative care team
22
Q

What is the triple assessment?

A
  1. Clinical
  2. Radiological
  3. Pathological
23
Q

Describe the clinical aspect of triple assessment

A
  • inspection and palpation of the breast

- checking lymph nodes in the neck and axilla

24
Q

Describe the radiological aspect of triple assessment

A

mammogram and ultrasound

25
Describe the pathological aspect of triple assessment
biopsy, FNA, core biopsy
26
Describe the current treatment options for breast cancer
``` Neoadjuvant therapy - endocrine (aromatase inhibitors) - chemotherapy (anthracyclines and taxanes) - hercpetin/pertuzumab/lapatinib Surgery Adjuvant therapy - endocrine - chemotherapy - radiotherapy - biological agents ```
27
What are the surgical options?
- wide local excision (breast conserving surgery) - mastectomy - simple vs skin sparing - axillary lymph nodes - sentinel lymph node biopsy, axillary node sampling, axillary node clearance
28
What are the three options for endocrine therapy?
Tamoxifen - a competitive inhibitor of estradiol Aromatase inhibitors - significantly lower serum estradiol concentration Ovarian suppression - GnRH agonists suppress ovarian function
29
What are the two categories of biological therapies?
``` Extracellular mAbs - herceptin/trastuzumab (HER2) - pertuzumab (HER2) Intracellular TKIs - lapatinib (EGFR/HER2) ```
30
What is the major new therapy for the future?
Tumour vaccines - tumour antigens - MUC1, HER2 - tumour cells - dendritic cells/T-cells - exosomes Oncolytic viral therapy? Gene therapy?
31
How does OCP and HRT affect breast cancer risk?
OCP --> 14% increase, baseline after 10 years | HRT --> 66% increase, baseline after 2 years